Client Testimonials


“The Neocure Group has played a pivotal role in seeking and achieving higher reimbursement for our company’s implantable device. Neocure used their expertise and experience with Medicare payment systems to execute a sophisticated strategy which resulted in the correct payment category for our technology. Working with Neocure has given us the ability to navigate complex payment systems to ensure improved access to our technology for patients, physicians and providers.”

—Dan Moore, President & CEO, Cyberonics, Inc.

“Neocure has been instrumental in helping us create a solid and dynamic reimbursement strategy for our product in light of a changing economic environment. They take into consideration all the relevant factors and intricacies with confidence and poise. The previous experiences of Randel Richner and her team from working for various medical device companies allows them to recommend actionable plans because they have the business mindset and understand a company’s internal needs, goals, interests, and stakeholders. Neocure has strong and valuable connections within and beyond the reimbursement and health economics community. They are the eyes and ears for our team that help us create a unified and cohesive voice internally and to various reimbursement and coverage interests groups.”

—Adrienne Fazio, Strategic Planning Manager, MEDRAD Interventional

“I’ve used the Neocure group to support several key projects and at various companies with excellent results! Neocure was able to provide economic insights that I could share with senior management on key opportunities to ensure a clinical and economic development program to capture the full value of our technologies. In another effort, Neocure reimbursement experts helped avert a crisis with solid, experience-based advice that allowed my team to reverse a disadvantageous situation and avoid lost product sales. I recommend the Neocure team to all executives with limited time and big problems to solve.”

—Betsy J. Lahue, Head of Health Economics, Epidemiology & Value Planning,
   AMAG Pharmaceuticals

“The Neocure Group has the unique ability to understand complicated reimbursement policies while appreciating and meeting the business goals and objectives of the client. Their ability to quickly understand and define a market opportunity or challenge and systematically develop a thorough, organized plan to attack the issue is a rare combination.”

—Bernie Lyons, President & CEO of Direct Flow Medical, Inc.

“My company contracted Neocure to provide us with a strategic plan for attaining device reimbursement, and they proved to be a perfect fit for our needs. The work delivered was exceptionally thorough, well-presented, and enabled us to come away with clear directions and timelines. Without a doubt, Randel is a leading expert in the industry – and in forming Neocure she has assembled a core group of complementary talent.”

—Alan Newton, President, Janus Development Group, Inc.

“Kimbell and Associates has aligned with the Neocure Group on a number of occasions to serve our client’s interest. Our firm takes a strategic approach to monitoring and synthesizing new developments, pertinent changes, and shifts related to the legislative and regulatory landscape for the life sciences industry. Neocure has distinctive expertise within the cardiovascular disease state, a substantive historical perspective on the evolution of the hospital outpatient prospective payment system, and data analytic aptitude. The combination of our government affairs and health policy capabilities with Neocure’s competence in reimbursement strategy has resulted in unparalleled success for a number of shared clients.”

—Jeffrey Kimbell, CEO of Jeffrey Kimbell & Associates